🇺🇸 FDA

Company profile · Sponsor

Janssen

Janssen Pharmaceutica N.V.

EC38B22 · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

Janssen (EC38B22) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker EC38B22
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. 0.9% Sodium Chloride, JNJ-78901563

    Janssen

    Invasive Extraintestinal Pathogenic Escherichia coli Disease

    phase 3 small molecule active

    1 trial

  2. RILPIVIRINE , JNJ-16150108

    Janssen

    HIV-1 Infection

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is Janssen?

Janssen (EC38B22) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Janssen sponsor?

We track 2 ClinicalTrials.gov-linked programs for Janssen, including 0.9% Sodium Chloride, JNJ-78901563 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Janssen company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.